TET3 and endometrium adenocarcinoma: In vitro studies demonstrated that estrogen alone or in combination with progesterone can impact on increase of TET3 expression in human endometrial epithelial cells (HES)67, as well as in increase of TET3 protein in endometrial adenocarcinoma cell lines (AN3)68.